NCT05884164

Brief Summary

In recent years , the popularity of ultrasound-guided fascial plane blocks has increased in achieving an effective postoperative analgesia and hence achieving enhanced recovery after surgery (ERAS) . Mastering the use of ultrasound encourages anesthetists on the frequent use of regional anesthesia . Fascial plane blocks are increasingly becoming a part of multimodal analgesia as an alternative pain management strategy in cardiac surgery. Various regional techniques especially paravertebral plane blocks have been recently described to reduce the postoperative pain in cardiac surgery with enhanced recovery . Ultrasound-guided erector spinae plane block is a recently introduced technique for regional analgesia in thoracic neuropathic pain, rib fractures, and breast surgeries. This study aims to compare between the two techniques regarding their peri-operative analgesic effect and their impact on enhanced recovery after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 24, 2022

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

April 1, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 1, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 7, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

2.5 years

First QC Date

April 1, 2023

Last Update Submit

April 26, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • intraoperative opioid consumption

    Fentanyl in micrograms intraoperatively

    Through intraoperative period, average of 6 hours

  • Postoperative opioid consumption

    morphine in milligram postoperatively

    For 24 hours after extubation

Secondary Outcomes (6)

  • Time for extubation

    24 hours postoperative

  • Time for ambulation

    Through the stay of the patient in ICU postoperatively, average of 2 days.

  • Postoperative respiratory depression

    24 hours after extubation

  • Postoperative respiratory depression

    24 hours after extubation

  • Postoperative respiratory depression

    24 hours after extubation

  • +1 more secondary outcomes

Study Arms (2)

Erector spinae group

ACTIVE COMPARATOR

Patients will receive erector spinae plane block after general anaesthesia .

Procedure: Thoracic erector spinae plane block

Paravertebral block group

ACTIVE COMPARATOR

Patients will receive paravertebral plane block after general anaesthesia .

Procedure: Thoracic paravertebral plane block

Interventions

After induction of general Anaesthesia,a high frequency ultrasound probe will be placed in a longitudinal orientation 3 cm from the midline. Once the erector spinal muscle and the transverse processes are identified, spinal needle will be inserted after standard skin disinfection in a caudal to cephalad direction using a sterile probe cover until the tip lay in the interfacial plane deep to the erector spinal muscle. After hydrolocalization with ml normal saline, this plane will be opened and 20 ml of 0.25 %bupivacaine will be administered for block performance

Erector spinae group

After induction of general Anaesthesia ,with the probe in the longitudinal paramedian position, it is then moved from medial to lateral direction to appreciate the saw tooth appearance of the facet joints close to the midline which changes to long finger-like shadow of the transverse process as the probe is moved slightly laterally. Repositioning the probe over the transverse process ensuring the space of interest is in the middle of the probe once again one should appreciate the intercostal muscles and the dense bright white line of the pleura in between the shadows of the transverse processes. The needle is then introduced at the caudal end of the probe in plane in a caudal to cranial direction aiming for the angle between the bottom of the transverse process and the pleura. Once position is confirmed, 20 ml of 0.25% bupivacaine will be administered for the block performance.

Paravertebral block group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with American Society of Anesthesiologists (ASA) score III.
  • Patients aged ≥ 18 years old.
  • Patients scheduled for minimally invasive mitral valve replacement through a right mini thoracotomy.

You may not qualify if:

  • Patients refusing to be involved in this study.
  • Patients with ASA score \> III.
  • Patients aged \< 18 years.
  • Patients with local infection at the site of needle puncture.
  • Patients with known hypersensitivity to local anesthetic (LA).
  • Patients with hepatic or renal impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, Abbasya, 11213, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Galal A El Kadi, MD

    Ain Shams University

    STUDY CHAIR
  • Mohamed S Zaki, MD

    Ain Shams University

    STUDY CHAIR
  • Mona M Ammar, MD

    Ain Shams University

    STUDY CHAIR
  • Islam A Abdelmouty, MD

    Ain Shams University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2023

First Posted

June 1, 2023

Study Start

March 24, 2022

Primary Completion

October 7, 2024

Study Completion

March 30, 2025

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations